How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis (2017)

First Author: Thomas K
Attributed to:  The UK Centre for Tobacco and Alcohol Studies (UKCTAS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2016-015414

PubMed Identifier: 28624760

Publication URI: http://europepmc.org/abstract/MED/28624760

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 6

ISSN: 2044-6055